Lenti-multi-CRISPR Citations (8)
Originally described in: An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting.Cao J, Wu L, Zhang SM, Lu M, Cheung WK, Cai W, Gale M, Xu Q, Yan Q Nucleic Acids Res. 2016 Nov 2;44(19):e149. Epub 2016 Jul 25. PubMed Journal
Articles Citing Lenti-multi-CRISPR
| Articles |
|---|
| The multiplexed CRISPR targeting platforms. Cao J, Xiao Q, Yan Q. Drug Discov Today Technol. 2018 Aug;28:53-61. doi: 10.1016/j.ddtec.2018.01.001. Epub 2018 Feb 4. PubMed |
| Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes. Cai EP, Ishikawa Y, Zhang W, Leite NC, Li J, Hou S, Kiaf B, Hollister-Lock J, Yilmaz NK, Schiffer CA, Melton DA, Kissler S, Yi P. Nat Metab. 2020 Sep;2(9):934-945. doi: 10.1038/s42255-020-0254-1. Epub 2020 Jul 27. PubMed |
| A ubiquitin switch controls autocatalytic inactivation of the DNA-protein crosslink repair protease SPRTN. Zhao S, Kieser A, Li HY, Reinking HK, Weickert P, Euteneuer S, Yaneva D, Acampora AC, Gotz MJ, Feederle R, Stingele J. Nucleic Acids Res. 2021 Jan 25;49(2):902-915. doi: 10.1093/nar/gkaa1224. PubMed |
| Merkel Cell Carcinoma Sensitivity to EZH2 Inhibition Is Mediated by SIX1 Derepression. Gartin AK, Frost TC, Cushman CH, Leeper BA, Gokhale PC, DeCaprio JA. J Invest Dermatol. 2022 Oct;142(10):2783-2792.e15. doi: 10.1016/j.jid.2022.03.008. Epub 2022 Mar 22. PubMed |
| GCAF(TMEM251) regulates lysosome biogenesis by activating the mannose-6-phosphate pathway. Zhang W, Yang X, Li Y, Yu L, Zhang B, Zhang J, Cho WJ, Venkatarangan V, Chen L, Burugula BB, Bui S, Wang Y, Duan C, Kitzman JO, Li M. Nat Commun. 2022 Sep 12;13(1):5351. doi: 10.1038/s41467-022-33025-1. PubMed |
| GALNT2 sustains glioma stem cells by promoting CD44 expression. Liu Y, Chen P, Xu L, Wang B, Zhang S, Wang X. Aging (Albany NY). 2023 Mar 25;15(6):2208-2220. doi: 10.18632/aging.204609. Epub 2023 Mar 25. PubMed |
Interleukin-1alpha release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity.
Hanggi K, Li J, Gangadharan A, Liu X, Celias DP, Osunmakinde O, Keske A, Davis J, Ahmad F, Giron A, Anadon CM, Gardner A, DeNardo DG, Shaw TI, Beg AA, Yu X, Ruffell B.
Cancer Cell. 2024 Nov 13:S1535-6108(24)00402-1. doi: 10.1016/j.ccell.2024.10.014.
PubMed
Associated Plasmids |
| Molecular Insights into the Regulation of GNPTAB by TMEM251. Yang X, Doray B, Venkatarangan V, Jennings BC, Henn D, Liang J, Zhao H, Zhang W, Zhang B, Yu L, Chen L, Kornfeld S, Li M. bioRxiv [Preprint]. 2024 Dec 5:2024.12.05.627003. doi: 10.1101/2024.12.05.627003. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.